PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Hoth Therapeutics, Inc.
Filed: April 4, 2022
Period of Report: April 4, 2022
Accession Number: 0001213900-22-017823

View Document ↗ View on SEC.gov ↗